The appendicitis market is projected to reach USD 9547.08 Million by 2030 at 4.10% CAGR during the forecast period 2022-2030
Appendicitis is a common cause of acute abdominal pain. It occurs when the appendix is blocked by stool, foreign body, or cancer. Infection is the leading cause of appendicitis in some patients. Growing geriatric population, rise in incidences of appendicitis, and increasing disease awareness drives the growth of the global appendicitis market. However, stringent regulatory policies are likely hampering market growth. The increasing prevalence of appendicitis, such as acute appendicitis is driving the growth of the global appendicitis market.
Appendicitis is the inflammation of the vermiform appendix. The vermiform appendix is a hollow organ which is located at the tip of cecum that is present at the right lower part of the abdomen. This inflammation can occur in almost any area of the abdomen. It is also one of the most common causes of abdominal pain in adults and children. Appendicitis could be diagnosed with the help of physical examination and laboratory studies. It occurs when the appendix is blocked due to a foreign body, cancer, or by stool. The prevalence of acute appendicitis is more as compared to chronic appendicitis. Around 8.6% of men and 6.7% of female worldwide are suffering from acute appendicitis. Computed tomography (CT) is frequently used for the diagnosis of acute appendicitis, and it gives more accurate results as compared to other diagnostic tests. CT plays a main role in the decision-making process in acute appendicitis and is considered as the first-line imaging modality in the diagnosis of acute appendicitis. To overcome this appendicitis appendectomy is considered as the first line treatment. In developing countries, growth in the appendicitis market is propelled by increasing government investments in healthcare. The global appendicitis market is expected to grow due to the increasing prevalence of appendicitis, and rising demand for diagnostic and treatment options of appendicitis.
Global Appendicitis Market Revenue, by Type, 2024 (USD Million)
Sources: MRFR Analysis
The acute segment is expected to lead the market and register a substantial CAGR to reach USD 9,518.69 million by the end of 2024. The acute diagnostic tests are most widely used as there is an increasing the prevalence of the infectious disease across the globe. However, the chronic segment is projected to exhibit the highest CAGR of 3.73% from 2019 to 2024.
Global Appendicitis Market Share, by Region, 2018 (%)
Sources: MRFR Analysis
North America is expected to dominate the market. The market growth in this region is mainly due to the incidence of appendicitis and subsequently increasing awareness regarding the disease and the growing demand for effective treatment methods. North America accounted for the largest market share of 39.8% in 2018, and the regional market is projected to register a CAGR of 4.06% during the forecast period. Latin America is one of the leading markets in the region, accounting for the largest market share during the review period.
The European market is estimated to exceed Substantial value by 2030. Continuous development in molecular diagnostic products and the rising prevalence of infectious disease are driving the growth of the appendicitis market in the region. Italy is the major contributor to the growth of the regional market, followed by the UK.
The prominent players in the global appendicitis market are Johnson & Johnson Services Inc (US), Pfizer Inc (US), Lupin (India), Siemens (Germany), Koninklijke Philips NV (Netherlands), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cook (US), Medtronic (Ireland), Teva Pharmaceutical Industries Ltd (Israel)
The players operating in the global appendicitis market are focusing on product launches, along with expanding their global footprints by entering untapped markets.
Global Appendicitis Market, by Type
Global Appendicitis Market, by Diagnosis & Treatment
- Ultrasound Imaging
- CT Scan
Global Appendicitis Market, by End User
- Hospitals & Clinics
- Diagnostic Centers
Global Appendicitis Market, by Region
- Rest of Europe
- Australia & New Zealand
- Southeast Asia
- Rest of Asia-Pacific
Rest of the World
- Middle East
- South America
Available Additional Customizations
Company Profiles of Key Regional Players
- McNeil Pharmaceuticals
- Retailers, distributors, and wholesalers
- Governments, associations, and industrial bodies
- Investors and trade experts
- Medical device manufacturers
- Medical device suppliers
- Medical research laboratories
- Research and development (R&D) companies
- Market research and consulting service providers
- Potential investors